Konstantin Viktorovich Pshenisnov

Konstantin Viktorovich Pshenisnov

Auto-generated profile, based on publicly available information

Konstantin Viktorovich Pshenisnov

St. Petersburg State Pediatric Medical University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EAEkaterina I. Alekseeva
Ekaterina I. Alekseeva
MBMaya D. Bakradze
Maya D. Bakradze
ABAlexander A. Baranov
Alexander A. Baranov
TBTatiana T. Batysheva
Tatiana T. Batysheva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has revised guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

6 June 2018 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ASA. N. Shmakov
A. N. Shmakov
YAYu. S. Aleksandrovich
Yu. S. Aleksandrovich
KPK. V. Pshenisnov
K. V. Pshenisnov
DZD. V. Zabolotskiy
D. V. Zabolotskiy
SRS. A. Razumov
S. A. Razumov
В статье представлен проект клинических рекомендаций по оказанию реанимационной помощи детям, нуждающимся в межгоспитальной транспортировке, разработанный с учетом территориальных особенностей Российской Федерации. Детально рассмотрены правовые аспекты организации службы межгоспитальной транспортировки, возможные побочные эффекты транспортировки, дана характеристика авиационного и наземного санитарного транспорта, отражены его основные достоинства и недостатки. Предложена оценка риска транспортировки, выраженная в рангах, соответствующих продолжительности безопасного времени транспортировки. Приведены оригинальные шкалы оценки риска транспортировки, основанные на необходимости проведения экстренной регидратации, инотропной и вазопрессорной терапии, а также респираторной поддержки. Особое внимание уделено подготовке детей в критическом состоянии к межгоспитальной транспортировке, изложен детальный протокол мероприятий интенсивной терапии, мониторинга и ухода на этапе транспортировки. Описаны целевые показатели стабилизации состояния пациента в ближайшие шесть часов после транспортировки. Использование представленных ключевых принципов безопасной транспортировки позволит существенно повысить качество оказания медицинской помощи детям, нуждающимся в переводе в специализированные стационары.

10 June 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EBElena N. Baybarina
Elena N. Baybarina
ABAlexander A. Baranov
Alexander A. Baranov
EVElena A. Vishneva
Elena A. Vishneva
NZNadezda N. Zvereva
Nadezda N. Zvereva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has developed guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

7 May 2022 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
YAYu. S. Aleksandrovich
Yu. S. Aleksandrovich
DID. O. Ivanov
D. O. Ivanov
EPE. Yu. Pavlovskaya
E. Yu. Pavlovskaya
KPK. V. Pshenisnov
K. V. Pshenisnov
Alevtina Mikhailovna SavichevaAlevtina Mikhailovna Savicheva
Alevtina Mikhailovna Savicheva
ЕПЕ. Ю. Павловская
Е. Ю. Павловская
Clarification of etiology and identification of infectious agents in critically ill newborns is a very urgent problem of neonatal resuscitation.The objective. To study the characteristics of microbiota in critically ill newborns at admission to the intensive care unit (ICU) of a specialized hospital.Subjects and Methods. 165 critically ill newborns were examined, and bacteriological tests of blood, feces, and saliva were performed.Results. Positive culture results were obtained in 40 (24%) patients. The most frequent causative agent was S. epidermidis (47.5%). The detection rate of E. faecalis amounted to 15%, S. haemolyticus ‒ 15%, C. albicans – 12.5%, and K. pneumoniae ‒ 10%. Microorganisms were isolated from feces in 70% of cases, from the oral cavity in 62.5%, and from blood in 12.5%. E. faecalis was equally frequent at all three sites (5%).Conclusion. In 76% of patients, no neonatal infectious agent was isolated at admission to ICU of a specialized hospital that is most likely associated with the early administration of antibacterial drugs in the first hours of life of the newborn.

11 March 2020 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
PDF file
KPK. V. Pshenisnov
K. V. Pshenisnov
YAYu. S. Aleksandrovich
Yu. S. Aleksandrovich
Background. Massive blood loss is one of the main causes of deaths and complications both in patients requiring extensive surgical interventions and those with severe trauma.Aim. To analyse available publications devoted to the definition, pathogenesis, diagnosis and intensive care of acute massive blood loss in children.Materials and methods. The conducted analysis involved 102 publications by Russian and foreign authors from the PubMed database devoted to the problem of massive blood loss in children.General findings. The paper presents modern definitions of massive blood loss in children. Special attention is paid to the pathogenesis, diagnosis and treatment of massive blood loss in severe trauma cases. The principles of correcting the deficiency of circulating blood volume, the use of inotropic and vasopressor drugs, as well as the elimination of severe anemia and hemostasis disorders, are considered. Publications devoted to the search for an optimal ratio of globular and plasma volumes during the transfusion of blood components are reviewed. It is shown that the reviewed publications report conflicting opinions regarding the use of antifibrinolytic medications. At the same time, the high efficiency of tranexamic acid and its positive effect on the functional outcome in patients with severe trauma is demonstrated. In order to optimize approaches to the management of massive blood loss in children, additional multicenter studies are required. These studies should consider the effect of the underlying disease that caused massive blood loss, as well as the treatment and diagnostic capacity of hospitals.

30 December 2024 in Pediatrician (St. Petersburg)
Verified
Journal Article
Open access
PDF file
YAYuri S. Alexandrovich
Yuri S. Alexandrovich
EBEkaterina N. Balashova
Ekaterina N. Balashova
IBIrina V. Boronina
Irina V. Boronina
AZAnna N. Zavyalova
Anna N. Zavyalova
LZLyubov S. Zolotareva
Lyubov S. Zolotareva
АСАлександрович Юрий Станиславович
Александрович Юрий Станиславович
Neonatal sepsis is one of the most severe diseases of the neonatal period with a high probability of developing multiple organ dysfunction, septic shock and an unfavorable outcome. The purpose of this publication is to present draft federal clinical guidelines for the treatment of sepsis in newborns, which were developed taking into account the principles of evidence-based medicine. During the preparation of clinical guidelines, key questions were formulated using the PIPOH formula: P (population) — patient population and disease characteristics (neonate with sepsis and septic shock); I (interventions) — intensive care measures; P (professionals) — target audience of clinical recommendations (anesthesiologists, intensive care physicians, neonatologists, pediatricians, surgeons, infectious disease doctors); O (outcomes) — expected outcomes that can be improved (patient outcomes, health system indicators, epidemiological indicators, etc.); H (health care setting) — place of medical care (outpatient clinic, hospital, intensive care unit). The project includes sections on the etiology, pathogenesis and diagnosis of sepsis in newborns. Particular attention is paid to the issues of microbiological diagnostics, identification of the pathogen, antibacterial therapy, respiratory and nutritional support, extracorporeal hemocorrection, the use of intravenous immunoglobulins. It has been demonstrated that one of the mandatory elements of therapy is the early initiation of enteral nutrition using breast milk, the use of which is one of the most effective methods for the prevention of late sepsis in premature newborns with low and extremely low birth weight.